Page last updated: 2024-08-26

paxilline and erucylphospho-n,n,n-trimethylpropylammonium

paxilline has been researched along with erucylphospho-n,n,n-trimethylpropylammonium in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aumailley, M; Cappuccini, F; Chometon, G; Jendrossek, V; Raducanu, A1

Other Studies

1 other study(ies) available for paxilline and erucylphospho-n,n,n-trimethylpropylammonium

ArticleYear
The membrane-targeted alkylphosphocholine erufosine interferes with survival signals from the extracellular matrix.
    Anti-cancer agents in medicinal chemistry, 2014, Volume: 14, Issue:4

    Topics: Animals; Antineoplastic Agents; Cell Adhesion; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Survival; Collagen Type I; Extracellular Matrix; Fibroblasts; Fibronectins; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Glioblastoma; Humans; Integrin beta1; Male; Mice; Organophosphates; Paxillin; Phosphorylation; Prostatic Neoplasms; Quaternary Ammonium Compounds

2014